Does adding an intra-aortic balloon pump (IABP) or Impella to VA-ECMO improve haemodynamics, cardiac energetics, and cardioprotective signalling in a sheep model of severe cardiogenic shock?
In a sheep model of cardiogenic shock, adding active LV unloading (IABP or Impella) to VA-ECMO reduces LV overload and positively modulates cardioprotective signalling, with Impella additionally improving cardiac energetics and reducing LV volumes.
BACKGROUND Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a commonly used in refractory cardiogenic shock (CS) but may exacerbate left ventricular (LV) loading conditions and impair cardiac energetics. Adjunctive LV unloading strategies are frequently combined with VA-ECMO to counteract these effects and potentially enhance myocardial recovery through activation of cardioprotective pathways. We hypothesized that adding an intra-aortic balloon pump (IABP) or Impella to VA-ECMO would alleviate LV overload, improve cardiac energetics, and modulate RISK/SAFE pathways. METHODS Severe CS was induced in sheep through coronary artery alcoholization. Animals were then randomly assigned to VA-ECMO alone, VA-ECMO with IABP, or VA-ECMO with Impella. ECMO blood flow was progressively increased from 25% to 100% of the baseline cardiac output (CO). RESULTS Twenty-four animals were analyzed. CS was characterized by a 37±2% decrease in CO, 52±10% increase in LV end-diastolic pressure (LVEDP), and lactate rising from 1.6±0.1 to 3.8±0.3 mmol/L (p<0.0001 for all). Both unloading strategies reduced LVEDP compared to VA-ECMO alone (-51 ± 6% with IABP, -58 ± 6% with Impella; p < 0.001), while only Impella reduced LV volumes and improved cardiac energetics. Phosphorylation of ERK and Akt in LV myocardium from the peri-infarcted area was significantly higher in both combined strategy groups. However, infarct size and apoptotic signalling did not differ between the groups. CONCLUSION Adding LV active unloading to VA-ECMO reduces LV overload, improves cardiac energetics, and positively modulates cardioprotective signalling pathways. These findings enhance our understanding of myocardial recovery in patients treated with combined VA-ECMO and LV unloading strategies.
Beurton et al. (Thu,) studied this question.